Watertown’s Lyndra strikes Alzheimer’s pact with Allergan worth up to $105M
September 07, 2017 at 07:01 AM EDT
Under the deal, the companies will seek to use Lyndra's technology to develop once-weekly formulations of Allergan’s drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|